Exosomal circGSE1, derived from HCC cells, could induce the expansion of Tregs by regulating the miR-324-5p/TGFBR1/Smad3 axis, and thus serves as a promising biomarker for HCC immunotherapy [107]. This evidence concerns the gene SMAD3 and hepatocellular carcinoma.